DiaMedica Therapeutics (DMAC) Inventory Average (2023)

DiaMedica Therapeutics (DMAC) posted quarterly Inventory Average of $516000.0 for Q4 2023, up 33.33% quarter-over-quarter from $387000.0 in Q3 2023.

DiaMedica Therapeutics (DMAC) Inventory Average (2023) Analysis & Trends

DiaMedica Therapeutics' Inventory Average history runs 1 years deep, the most recent figure standing at $516000.0 for Q4 2023.

In Q4 2023, Inventory Average changed N/A year-over-year to $516000.0; the TTM figure through Dec 2023 stood at $516000.0 (changed N/A YoY), while the FY2023 annual figure was $179500.0, up 131.61% from the prior year.
Inventory Average for Q4 2023 stood at $516000.0, up from $387000.0 in the prior quarter.
The five-year high for Inventory Average was $516000.0 in Q4 2023, with the low at $67000.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	707.10 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	355,998.06
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	90.57 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	137.65 Mn
10	DiaMedica Therapeutics	360.22 Mn	360.22 Mn	-	-

Download Data